Accordingly, Ab that target MICA/B should trigger ADCC against MICA/B-expressing tumor cells to stimulate tumor cell elimination and, simultaneously, promote the formation of immune complexes with sMICA/B to facilitate their clearance by macrophages and interfere with the tumor immune escape mechanism mediated by sMICA/B. The gene discussed is MICA; the disease is neoplasm.